Perry Andrew

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 72% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Perry Andrew's trades of G1 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
246.54
Quantity 77,747 -26.6%
Value US$4,574,318
Transaction date
Sale
Price
131.81
Quantity 37,589 +11.6%
Value US$1,250,770
Transaction date
Sale
Price
253.85
Quantity 47,077 +45.2%
Value US$979,601
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-08 2024-07-05
S Sale
77,747 -26.6%
246.54
US$4,574,318 		77,747 -26.6% 246.54 US$4,574,318
2024-05-15 2024-05-13
S Sale
37,589 +11.6%
131.81
US$1,250,770 		37,589 +11.6% 131.81 US$1,250,770
2024-01-08 2024-01-03
S Sale
47,077 +45.2%
253.85
US$979,601 		47,077 +45.2% 253.85 US$979,601
2024-01-08 2024-01-03
S Sale
379 -0.4%
3.12
US$1,182 		379 -0.4% 3.12 US$1,182
2023-07-07 2023-07-05
PlS Planned sale
355 -0.6%
2.45
US$871 		355 -0.6% 2.45 US$871
2023-01-05 2023-01-04
S Sale
820 -3.7%
5.58
US$4,572 		820 -3.7% 5.58 US$4,572